Clinical Trial: Advanced Cardiovascular Imaging of the Systemic Effects of Inflammasome Activation
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Myocardial Infarction
Study Type: INTERVENTIONAL
Official Title: Advanced Cardiovascular Imaging of the Systemic Effects of Inflammasome Activation
Brief Summary:
Subjects with urgently reperfused type I myocardial infarction (MI) will be recruited and randomized to receive either placebo or the oral inflammasome (NLRP3) inhibitor dapansutrile.The primarily outcome measure will be carotid plaque volume change over 6 months; secondary outcome measures will be plaque inflammatory activity and coronary microvascular function.
Read more